Cargando…

Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children’s Oncology Group Study ANBL0931

Detalles Bibliográficos
Autores principales:	Ozkaynak, M. Fevzi, Gilman, Andrew L., London, Wendy B., Naranjo, Arlene, Diccianni, Mitchell B., Tenney, Sheena C., Smith, Malcolm, Messer, Karen S., Seeger, Robert, Reynolds, C. Patrick, Smith, L. Mary, Shulkin, Barry L., Parisi, Marguerite, Maris, John M., Park, Julie R., Sondel, Paul M., Yu, Alice L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055015/ https://www.ncbi.nlm.nih.gov/pubmed/30046297 http://dx.doi.org/10.3389/fimmu.2018.01641

Ejemplares similares

A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children’s Oncology Group Study ANBL0931
por: Ozkaynak, M. Fevzi, et al.
Publicado: (2018)

Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial
por: de Alarcon, Pedro A., et al.
Publicado: (2017)

Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy
por: Marachelian, Araz, et al.
Publicado: (2016)

A Pilot Study of Tandem High Dose Chemotherapy with Stem Cell Rescue as Consolidation for High Risk Neuroblastoma: Children’s Oncology Group study ANBL00P1
por: Seif, Alix E., et al.
Publicado: (2013)

KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children’s Oncology Group
por: Erbe, Amy K, et al.
Publicado: (2023)

1418. Injections and Infections: Understanding Harm Reduction Utilization in a Rural State
por: Thakarar, Kinna, et al.
Publicado: (2020)

The effects of myeloablative or non-myeloablative total body irradiations on intestinal tract in mice
por: Zhu, Shengyun, et al.
Publicado: (2021)

Chimeric Antibody c.8B6 to O-Acetyl-GD2 Mediates the Same Efficient Anti-Neuroblastoma Effects as Therapeutic ch14.18 Antibody to GD2 without Antibody Induced Allodynia
por: Terme, Mickaël, et al.
Publicado: (2014)

Isotretinoin-induced skeletal hyperostosis
por: Graf, Scott W, et al.
Publicado: (2014)

The Premalignant Ancestor Cell of t(14;18)(+) Lymphoma
por: Brisou, Gabriel, et al.
Publicado: (2021)

Correction: The effects of myeloablative or non-myeloablative total body irradiations on intestinal tract in mice
Publicado: (2022)

Acquired resistance to venetoclax (ABT-199) in t(14;18) positive lymphoma cells
por: Bodo, Juraj, et al.
Publicado: (2016)

In vivo synergy of radiation and hu14.18-IL2 immunocytokine results in a memory T cell response in a syngeneic murine melanoma model
por: Morris, Zachary S, et al.
Publicado: (2014)

A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu14.18K322A in recurrent/refractory solid tumors
por: Bishop, Michael W., et al.
Publicado: (2020)

HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy
por: Erbe, Amy K., et al.
Publicado: (2017)

1418. Clinical Characteristics of Vertebral Osteomyelitis in Cancer Patients
por: Fukushima, Kazuaki, et al.
Publicado: (2019)

Comparison of Non-myeloablative Conditioning Regimens for Lymphoproliferative Disorders
por: Hong, Sanghee, et al.
Publicado: (2014)

Hypoacusia in a Patient Treated by Isotretinoin
por: Rosende, L., et al.
Publicado: (2011)

A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations
por: Atilla, Erden, et al.
Publicado: (2017)

The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas
por: Salaverria, Itziar, et al.
Publicado: (2023)

Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma
por: Goldberg, Jacob L, et al.
Publicado: (2020)

Presence of t(14;18) translocation in healthy individuals varies according to ethnic background in the Brazilian population
por: Levy, D., et al.
Publicado: (2017)

High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation
por: Nakamura, R, et al.
Publicado: (2002)

Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249)
por: Synold, Timothy W., et al.
Publicado: (2019)

Asynchronous telemedicine for isotretinoin management: A direct care pilot
por: Das, Shinjita, et al.
Publicado: (2022)

Complete genome sequence of Hirschia baltica type strain (IFAM 1418(T))
por: Chertkov, Olga, et al.
Publicado: (2011)

Synthesis and Biological Characterization of the New Glycolipid Lactose Undecylenate (URB1418)
por: Verboni, Michele, et al.
Publicado: (2022)

Signal One and Two Blockade Are Both Critical for Non-Myeloablative Murine HSCT across a Major Histocompatibility Complex Barrier
por: Langford-Smith, Kia J., et al.
Publicado: (2013)

Isotretinoin and psychopathology: a review
por: Kontaxakis, Vassilis P, et al.
Publicado: (2009)

Acute psychosis induced by isotretinoin
por: Rajagopal, Sundararajan
Publicado: (2014)

Isotretinoin-Induced Night Blindness
por: Madke, Bhushan, et al.
Publicado: (2015)

Isotretinoin and the Kidney: Opportunities and Threats
por: Forouzani-Haghighi, Bahareh, et al.
Publicado: (2020)

Acute Pancreatitis Caused by Isotretinoin
por: Ashraf, Muddasir
Publicado: (2020)

Gender differences in isotretinoin prescriptions during the COVID-19 pandemic at a U.S. academic medical center
por: Duan, Grace Y., et al.
Publicado: (2022)

Relapse of follicular lymphoma arising from a non‐t(14;18) clone
por: Otsuka, Yasuyuki, et al.
Publicado: (2020)

Correlation of t(14;18) translocation breakpoint site with clinical characteristics in follicular lymphoma
por: Panjan, Matej, et al.
Publicado: (2023)

Pilot experience with opebacan/rBPI (21) in myeloablative hematopoietic cell transplantation
por: Guinan, Eva, et al.
Publicado: (2015)

Isolated Follicles Enriched for Centroblasts and Lacking t(14;18)/BCL2 in Lymphoid Tissue: Diagnostic and Clinical Implications
por: Nybakken, Grant E., et al.
Publicado: (2016)

Angiolymphoid hyperplasia with eosinophilia: efficacy of isotretinoin?
por: El Sayed, Fouad, et al.
Publicado: (2006)

Exacerbation of inflammatory bowel disease with isotretinoin
por: Bharmal, Rabaab, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_c2sg17ti76vjnulhispbs6ihor